Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

Brief summary (registry, in English)

This study will assess whether an implantable defibrillator will increase the likelihood of survival in patients who have had a heart attack, have abnormal test results from a 24 hour heart monitor, and who have low normal heart function.

What you commit to

• Study type: Interventional · Phase 3
• Planned participants: 700
• From 18 Apr 2011 to the primary completion date, 31 Oct 2024
• 78 sites in 15 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (78)

Sites in registry order. Save your city in your profile to sort them by distance.